<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Wed, 16 Sep 2026 18:36:39 -0400--><rss version="2.0">
    <channel>
        <title>MAIA Biotechnology, Inc. (MAIA) Press Releases</title>
        <link>https://ir.maiabiotech.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/maiabiotech/files/theme/images/logo-sm.png</url>
                <title>MAIA Biotechnology, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/184/maia-biotechnology-doses-first-u-s-patient-in-ongoing</link>
                <pubDate>Wed, 16 Sep 26 08:15:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/184/maia-biotechnology-doses-first-u-s-patient-in-ongoing</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/183/maia-biotechnology-announces-open-market-purchases-of</link>
                <pubDate>Tue, 15 Sep 26 08:15:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/183/maia-biotechnology-announces-open-market-purchases-of</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/182/maia-biotechnology-delivers-oral-and-poster-presentations</link>
                <pubDate>Thu, 10 Sep 26 08:15:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/182/maia-biotechnology-delivers-oral-and-poster-presentations</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/181/maia-biotechnology-reports-strong-initial-efficacy-data-in</link>
                <pubDate>Wed, 08 Jul 26 09:45:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/181/maia-biotechnology-reports-strong-initial-efficacy-data-in</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/180/maia-biotechnology-completes-international-enrollment-in</link>
                <pubDate>Thu, 25 Jun 26 08:08:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/180/maia-biotechnology-completes-international-enrollment-in</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/179/maia-biotechnology-opens-enrollment-for-phase-2-expansion</link>
                <pubDate>Thu, 18 Jun 26 08:30:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/179/maia-biotechnology-opens-enrollment-for-phase-2-expansion</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/178/maia-biotechnology-activates-and-opens-enrollment-at-second</link>
                <pubDate>Wed, 10 Jun 26 09:15:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/178/maia-biotechnology-activates-and-opens-enrollment-at-second</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/177/maia-biotechnology-reports-strong-enrollment-and-dosing</link>
                <pubDate>Thu, 04 Jun 26 09:45:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/177/maia-biotechnology-reports-strong-enrollment-and-dosing</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[MAIA Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 THIO-101 Trial Expansion]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/176/maia-biotechnology-receives-fda-clearance-to-open-u-s</link>
                <pubDate>Wed, 03 Jun 26 09:45:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/176/maia-biotechnology-receives-fda-clearance-to-open-u-s</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[MAIA Biotechnology Announces Open Market Purchases by CEO and Director]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.maiabiotech.com/news-events/press-releases/detail/175/maia-biotechnology-announces-open-market-purchases-by-ceo</link>
                <pubDate>Tue, 02 Jun 26 09:45:00 -0400</pubDate>
                <guid>https://ir.maiabiotech.com/news-events/press-releases/detail/175/maia-biotechnology-announces-open-market-purchases-by-ceo</guid>
                                                                            </item>
            </channel>
</rss>